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Background: Biomass smoke is the leading cause of COPD in developing countries such 
as Turkey. In rural areas of Turkey, females are more exposed to biomass smoke because of 
traditional lifestyles.
Aim: The aim of this study was to determine the adverse effects of biomass smoke on pulmo-
nary functions and define the relationship between duration in years and an index (cumulative 
exposure index) with altered pulmonary function test results.
Participants and methods: A total of 115 females who lived in the village of Kağizman 
(a borough of Kars located in the eastern part of Turkey) and were exposed to biomass smoke 
were included in the study. The control group was generated with 73 individuals living in the 
same area who were never exposed to biomass smoke.
Results: Twenty-seven (23.8%) females in the study group and four (5.5%) in the control group 
had small airway disease (P=0.038). Twenty-two (19.1%) females in the study group and ten 
(13.7%) in the control group had obstruction (P=0.223). Twenty (17.3%) females in the study 
group who were exposed to biomass smoke had restriction compared with ten (13%) in the 
control group (P=0.189). The duration needed for the existence of small airway disease was 
16 years, for obstructive airway disease was 17 years, and for restrictive airway disease was 
17 years. The intensity of biomass smoke was defined in terms of cumulative exposure index; 
it was calculated by multiplying hours per day, weeks per month, and total years of smoke 
exposure and dividing the result by three.
Conclusion: Exposure to biomass smoke is a serious public health problem, especially in rural 
areas of developing countries, because of its negative effects on pulmonary functions. As the 
duration and the intensity of exposure increase, the probability of having altered pulmonary 
function test results is higher.
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Introduction
In the urban areas of developing countries such as Turkey, biomass (eg, wood, animal 
dung, crop residues) is used as a source of energy.1,2 Exposure to biomass smoke is the 
leading cause of COPD, especially in developing countries.3 A half of COPD deaths are 
due to biomass exposure, and 75% of these deaths occur in females.3,4 Females are more 
exposed to biomass smoke than men in Turkey because of traditional lifestyles in rural 
areas. Carbon monoxide, nitrous oxide, sulfur oxide, formaldehyde, and polycyclic organic 
matter, including carcinogens such as benzopyrene, are all products of biomass smoke.5 
These microparticulate products reach the peripheral airways and produce adverse effects 
on pulmonary functions.6 The primary aim of this study was to determine the difference 
of pulmonary functions between females who were exposed to biomass smoke and those 
who were not and the secondary aim was to determine the time course relationship with 
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altered pulmonary function test (PFT) results and define the 
importance of intensity of smoke on pulmonary functions, 
with the calculation of a new index (cumulative exposure index 
[CEI]), which has not been described in the literature before.
Participants and methods
There is a tradition in the village of Kağizman (a borough of 
Kars located in the eastern part of Turkey) that females are 
responsible for the cooking of bread in their houses. People 
are exposed to heavy smoke due to the cooking conditions 
(lack of chimney and poor ventilation; Figure 1). Girls start 
making bread at the age of 15 years, and the daily exposure 
to smoke is between 2 hours and 4 hours; they usually cook 
1 day/wk, ie, two to four times per month. They use organic 
wastes for burning fire, eg, dry animal dung (manure), rather 
than wood or charcoal, as the fuel source (Figure 2). Our only 
inclusion criterion was screening the pulmonary functions in 
females who were exposed to biomass smoke. We had visits 
to the village and were able to screen 474 females who were 
exposed to biomass smoke. There are some conditions and 
comorbidities that may affect the pulmonary functions. Smok-
ing is the leading cause of COPD; therefore, we eliminated 
females who were current or former smokers. Cardiovascular 
diseases are included in the comorbidities of COPD, and a 
volume overload due to heart failure or renal failure may affect 
PFT results negatively. Asthma is another important disease 
that results in altered PFT results; therefore, females who 
had history of allergy and asthma were excluded. Due to its 
inflammatory process, respiratory tract infection may narrow 
the airways with secretions and may affect PFT results, and 
hence those who received therapy due to upper or lower respi-
ratory infections in the last 1 month were excluded. The final 
study group comprised 115 females who were purely exposed 
to biomass smoke (Table 1). A control group was generated 
with 73 healthy individuals who lived in the same area and 
had never been exposed to biomass smoke. Both groups were 
matched according to age and body mass index.
All the research procedures were approved by the local 
ethical committee of the Public Health Directorship in Kars, 
and all participants provided written consent for the study. 
A PFT device (Spirolab III; MIR, Waukesha, WI, USA) was 
used on each patient after being calibrated by the technician, 
and forced expiratory volume in 1 second (FEV
1
), forced 
vital capacity (FVC), and forced expiratory flow during the 
25%–75% portion of the FVC (FEF 25–75) were recorded 
for both the study group and control group. PFT results were 
grouped in accordance with the guidelines of the European 
Respiratory Society and American Thoracic Society.7 FEF 
25–75 ,60% was accepted as small airway, FEV
1
/FVC 
,70% was accepted as obstructive, and FEV
1
/FVC .70% 
plus FVC ,80% was accepted as restrictive lung disease. 
After PFTs were performed in the study group and control 
group, the differences between the PFT results were evalu-
ated. In addition, the age at which the participants started to 
cook and hours per day, weeks per month, and total years 
of cooking were questioned. These variables correlated with 
the PFT results in the study group. The risk of duration in 
years for existence of pathologic PFT results was calculated. 
In addition, we tried to formulate an index (CEI) like cigarette 
Figure 1 People are exposed to heavy smoke due to the cooking conditions (lack 
of chimney and poor ventilation).
Figure 2 Dry animal dung (manure), rather than wood or charcoal, is used as the 
fuel source.
Table 1 Demographic properties of the females eliminated from 
the study
n %
smokers (current/former) 176 49
Pneumonia, upper respiratory tract infection 65 18
allergic asthma/rhinitis 55 15
Cardiovascular disease 35 10
Chronic renal failure 28 8
Total 359 100
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pack year to provide data for intensity of biomass exposure. 
This index was defined by multiplying the duration of bio-
mass exposure (in years) with the frequency of exposure 
(hours per day, weeks per month) and dividing the result by 
three. Finally, the correlation between CEI and pathologic 
PFT results was defined.
 
CEI
Hours per day Weeks per month Exposure duration in yea= × × r
3
 (1)
statistical analysis
Statistical Package for the Social Sciences 21.0 (IBM Corpo-
ration, Armonk, NY, USA) and MedCalc statistical software 
(MedCalc Software, Ostend, Belgium) were used for statistical 
analysis. Descriptive statistics (frequency, percentage, mean 
[min–max]) were used to evaluate the study data. The indepen-
dent sample t-test was used to compare parameters between 
the groups. A one-way analysis of variance test was used to 
compare the parameters between more than one group, and the 
Bonferroni test was used to determine the group that showed 
significant difference. Pearson’s correlation analysis was used 
to evaluate the relationship between PFT and independent 
variables (age, body mass index, age of starting cooking and 
hours per day, weeks per month, and years spent cooking). In 
addition, linear regression analyses were performed to evaluate 
the correlation between independent variables and PFT results. 
A receiver operating characteristic (ROC) curve analysis was 
performed to determine cutoff levels for duration in years and 
CEI for the existence of altered PFT results (small airway 
disease, obstruction, and restriction); moreover, sensitivity and 
specificity were calculated based on the cutoff value.
Results
A total of 188 females were evaluated in this study, of whom 
115 had been exposed to biomass smoke and 73 had had 
no exposure to biomass smoke. Table 2 shows the general 
characteristics and PFTs of the participants. The females 
who had been exposed to smoke were older than those in the 
control group, 33.4±7 years and 32.6±8 years, respectively. 
The study group and controls were grouped according to 
their PFT results: small airway disease, obstruction, and 
restriction. The median FEF 25–75 value was 70.0% in the 
study group and 77.0% in controls (P,0.001). The median 
FEV
1
/FVC value was 79.0% in the study group and 84.0% 
in controls (P,0.001). The median FEV
1
 value was 78.0% 
in the study group and 80% in controls (P=0.024), and the 
median FVC value was 81.0% in the study group and 84.0% 
in controls (P=0.036; Table 2 and Figure 3).
Twenty-seven (23.8%) females in the study group and 
four (5.5%) in the control group had small airway disease. 
Females who were exposed to biomass smoke had a higher 
probability of having small airway disease than those who 
were not (χ2=3.895, P=0.038). Twenty-two (19.1%) females 
in the study group and ten (13.7%) in the control group had 
obstruction (FEV
1
/FVC ,70%). Although the probability 
of having obstruction was higher in females who were 
exposed to biomass smoke, it was not statistically significant 
(χ2=0.933, P=0.223). Twenty (17.3%) females who were 
exposed to biomass smoke had restriction compared with ten 
(13%) in the control group (χ2=0.982, P=0.189; Table 3).
We also evaluated correlations between PFT results and 
some parameters such as age at starting to cook, how many 
hours per day and weeks per month spent cooking, and the 
duration of biomass exposure. The median values of the 
parameters for the patient group are shown in Table 4.
In the study group, 27 (23.8%) females had small air-
way disease and 22 (19%) had obstructive airway disease. 
Starting to make bread at younger age and more weeks and 
more years spent cooking were risk factors for the develop-
ment of both small airway disease and obstructive airway 
disease, whereas hours per day spent cooking was not a risk 
factor (Table 5).
In the study group, 20 (17%) of the females had restrictive 
pulmonary disease. When the parameters were evaluated in 
this group, it was observed that starting to cook at younger 
age, more hours per day, more weeks per month, and more 
years spent cooking were all risk factors for the development 
of restrictive lung disease (Table 5).
We also performed a correlation analysis between depen-
dent (FEV
1
, FEV
1
/FVC, FVC) and independent variables (age 
at starting to cook, hours per day, weeks per month, duration 
in years). For FEV
1
/FVC, the correlation analysis was statisti-
cally significant for duration of exposure to biomass smoke; 
as the duration of biomass exposure increased, FEV
1
/FVC 
was negatively affected. For FEV
1
/FVC, no correlation with 
Table 2 PFT values of the study group and the control group
Study group Control group P-value
Median IQR Median IQR
age (years) 33.4 30–37 32.6 22.5–44.5 0.110
BMI (kg/m2) 24.7 18–31 24.5 17–32 0.115
FeV1 (%) 78.0 71–82 80.0 76–87.5 0.023
FVC (%) 81.0 82–88 84.0 79–89 0.036
FeV1/FVC (%) 79.0 74–84 84.0 80.5–86 0.001
FeF 25–75 (%) 70.0 65–75 77.0 72–79 0.001
Note: Bold indicates a P-value ,0.05.
Abbreviations: PFT, pulmonary function test; IQr, interquartile range; BMI, body 
mass index; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; 
FEF 25–75, forced expiratory flow during the 25%–75% portion of the FVC.
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Figure 3 The difference of FeF 25–75 (A), FeV1/FVC (B), FeV1 (C), and FVC (D) results between the study group and control group.
Abbreviations: FEF 25–75, forced expiratory flow during the 25%–75% portion of the FVC; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
Table 3 Pathologic PFT results in the study group and control 
group
Study group, 
n (%)
Control group, 
n (%)
P-value
small airway disease  
(FeF 25–75 ,60[%])
27 (23.4) 4 (5.5) 0.038
Obstruction  
(FeV1/FVC ,70[%])
22 (19.1) 10 (13.0) 0.223
restriction  
(FeV1/FVC .70[%],  
FVC , 80[%])
20 (17.3) 10 (13.0) 0.189
Note: Bold indicates a P-value ,0.05.
Abbreviations: PFT, pulmonary function test; FeF 25–75, forced expiratory 
flow during the 25%–75% portion of the FVC; FEV1, forced expiratory volume in 
1 second; FVC, forced vital capacity.
Table 4 Median values of the evaluated parameters in the study 
group (n=115)
Median Min Max
age (years) 33.030 18 48
starting age (years) 18.300 15 22
hours per day 2.920 2 4
Weeks per month 2.500 1 4
Duration (years) 14.550 2 28
Abbreviations: Min, minimum; Max, maximum.
Table 5 Determination of the risk factors for the altered PFT 
results
Mean SD Mean SD P-value
FEF 25–75 
.60 (n=98)
FEF 25–75 
#60 (n=17)
starting age (years) 18.480 1.851 17.290 1.724 0.015
hours per day 2.880 0.579 3.180 0.636 0.060
Weeks per month 2.410 0.848 3.060 1.029 0.008
Duration (years) 13.400 4.854 21.180 2.811 0.001
FEV1/FVC .70 
(n=93)
FEV1/FVC #70 
(n=22)
starting age (years) 18.510 1.851 17.450 1.765 0.018
hours per day 2.900 0.572 3.000 0.690 0.522
Weeks per month 2.390 0.847 3.000 0.976 0.003
Duration (years) 13.120 4.750 20.590 3.232 0.001
FEV1/FVC 
.70, FVC 
.80% (n=95)
FEV1/FVC 
.70, FVC 
,80% (n=20)
starting age (years) 18.400 1.874 17.300 1.636 0.048
hours per day 2.880 0.583 3.400 0.516 0.009
Weeks per month 2.420 0.852 3.400 0.966 0.001
Duration (years) 13.780 4.901 22.600 2.989 0.001
Note: Bold indicates a P-value ,0.05.
Abbreviations: PFT, pulmonary function test; sD, standard deviation; FeF 25–75, 
forced expiratory flow during the 25%–75% portion of the FVC; FEV1, forced 
expiratory volume in 1 second; FVC, forced vital capacity.
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other independent variables was found. FEV
1
 was negatively 
correlated with weeks per month and duration in years. There 
was no correlation with starting age and hours per day for 
FEV
1
. Conversely, with the exception of age of starting to 
cook, a negative correlation with all the independent variables 
for FVC was found (Table 6).
By using the ROC curve analysis, we defined the dura-
tion for existence of small airway disease, obstruction, and 
restriction. The cutoff values were 16 years for small airway 
disease (sensitivity: 100%, specificity: 76.9%), 17 years for 
obstructive lung disease (sensitivity: 95.5%, specificity: 
69.9%), and 17 years for restrictive lung disease (sensitivity: 
100%, specificity: 74.3%; Figure 4).
The CEI was first defined by the present researchers in 
the literature. Females who had been exposed to biomass 
smoke and had altered PFT results had higher values of CEI 
compared with females who had PFT results with normal 
values (Table 7 and Figure 5). In addition, we calculated a 
cutoff value for pathologic PFT results using the ROC curve 
analysis. CEI was 34.7 for the existence of small airway 
disease, 42.7 for obstruction, and 45.3 for restriction (Table 8 
and Figure 6).
Discussion
This case control study has two major findings: first, females 
who are exposed to biomass smoke are at risk of developing 
altered pulmonary function (both obstructive and restrictive 
lung disease), and second, the duration of exposure to biomass 
smoke is important for the probability of altered pulmonary 
function. In our study, both obstructive and restrictive 
lung diseases were observed among females who had been 
exposed to biomass smoke. Chronic exposure to smoke may 
cause inflammatory reactions in the alveolar space and the 
bronchial wall.8 As expected, this was the reason for obstruc-
tive lung disease in our patients. In our study, we observed 
that as biomass exposure increased in quantity and intensity, 
the risk of appearance of COPD increased. Similar results 
were reported in the studies by Ramírez-Venegas et al9 and 
Regalado et al.10 These authors reported that advanced stages 
of COPD exist as the duration of biomass smoke increases. 
According to our data, females who are exposed to biomass 
smoke for .17 years are at risk of developing COPD. In the 
current literature, the risk of developing obstructive airway 
disease usually requires .20 years of exposure.9–11 The 
females in our study were exposed to more concentrated 
smoke because of the poor conditions in the places in which 
they cooked (Figure 1, no chimney and poor ventilation); 
massive smoke exposure may be the reason for altered PFT 
results of shorter duration.
In addition to obstruction, we also observed restrictive 
PFT results (FEV
1
/FVC .70, FVC ,80%) in 22 (19.1%) 
females in the study group. In the current literature, a few 
studies mention a restrictive pattern in biomass exposure: Kara 
et al12 and Arslan et al13 defined restrictive images (opacities, 
Table 6 Correlation analysis between PFT results and independent 
variables in the study group
Starting 
age
Hours  
per day
Weeks  
per month
Duration 
(years)
FeV1/FVC (%)
r 0.067 -0.106 -0.074 -0.488
P 0.480 0.261 0.429 0.001
FeV1 (%)
r 0.270 -0.172 -0.194 -0.749
P 0.004 0.067 0.038 0.001
FVC (%)
r 0.148 -0.236 -0.200 -0.522
P 0.114 0.011 0.032 0.001
Note: Bold indicates a P-value ,0.05.
Abbreviations: PFT, pulmonary function test; FeV1, forced expiratory volume in 
1 second; FVC, forced vital capacity.
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Figure 4 rOC curves of duration with small, obstructive, and restrictive airway diseases.
Notes: (A) ROC curve analysis for small airway disease (sensitivity, 100%; specificity, 76.9%). (B) rOC curve analysis for obstructive lung disease (sensitivity, 95.5%; 
specificity, 69.9%). (C) ROC curve analysis for restrictive lung disease (sensitivity, 100%; specificity, 74.3%).
Abbreviation: rOC, receiver operating characteristic.
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Table 7 Median values of CeI among biomass exposed women, who had altered and normal PFT results
n Mean ± SD P-value
small airway disease 0.001
FeF 25–75 .60 (%) 98 30.5±19.6
FeF 25–75 ,60 (%) 27 65.5±35.2
Obstruction 0.001
FeV1/FVC .70 (%) 93 31.4±20.6
FeV1/FVC ,70 (%) 22 71.0±34.6
restriction 0.001
FVC .80 (%) 95 32.4±21.2
FVC ,80 (%) 20 87.6±30.9
Abbreviations: CEI, cumulative exposure index; PFT, pulmonary function test; SD, standard deviation; FEF 25–75, forced expiratory flow during the 25%–75% portion of 
the FVC; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
Table 8 Cutoff values of CeI for small airway disease, obstruction, and restriction
CEI AUC 95% CI P-value Cutoff Sensitivity (%) Specificity (%)
small airway disease 0.876 0.802–0.930 ,0.001 34.7 94.1 71.4
Obstruction 0.828 0.747–0.892 ,0.001 42.7 63.6 86.0
restriction 0.930 0.867–0.969 ,0.001 45.3 90.0 84.8
Abbreviations: CEI, cumulative exposure index; AUC, area under the curve; CI, confidence interval.
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Figure 6 rOC curve analysis of CeI for small airway disease and obstructive and restrictive pulmonary diseases.
Abbreviations: rOC, receiver operating characteristic; CeI, cumulative exposure index.
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Figure 5 The difference of median values of CeI among all biomass exposed women based on PFT results.
Notes: The difference of CeI among all biomass exposed women with and without (A) small airway disease; (B) obstruction; and (C) restriction. Circles and stars indicate 
the cases out of 95% CI.
Abbreviation: CeI, cumulative exposure index.
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fibrotic bands) in computed tomography (CT) scans of patients 
who were exposed to biomass smoke. Septal enlargements, 
goblet cell metaplasia, glandular hyperplasia, and fibrosis can 
be observed histopathologically when the source of energy 
is something other than wood.14 In our study, the restrictive 
results can be explained by the source of energy used by the 
females (females-burned animal waste [manure]; Figure 2). 
Burning organic material such as manure may cause some kind 
of chemical reactions, which may be responsible for restrictive 
lung disease. Although some studies have defined a correla-
tion between restrictive lung disease and biomass exposure, 
none have mentioned the duration of exposure for the risk of 
developing restrictive lung disease.12,13 According to our data, 
females who are exposed to biomass smoke for .17 years are 
at risk of developing restrictive lung disease.
Twenty-seven (23.8%) females had small airway disease. 
In our study, small airway disease was observed among 
females who started to cook at younger ages, and the duration 
of exposure for the risk of developing small airway disease 
was 16 years. The results of Rinne et al15 do not support our 
findings. They claimed that exposure to biomass smoke at 
younger ages was not a risk factor for small airway disease. 
There must be a reaction in distal airways for small airway 
disease to appear. Biomass fuel combustion produces 
particles sized ,10 μm. Particles ,10 μm in diameter, 
particularly those ,2.5 μm, can penetrate deep into the lungs, 
especially into the peripheral airways.5,8
With the CEI calculation, we tried to define the impor-
tance of the intensity of biomass smoke. In this study, we did 
not accept exposure to biomass smoke to be like cigarette 
packet years. Cigarette smoke exhibits more homogeneous 
distribution compared with biomass smoke. Cigarette 
smokers smoke continuously, but the people in our study 
were exposed to biomass smoke for only a few hours per day, 
one day per week, or nearly every week. Pérez-Padilla et al16 
and Ekici at al17 described a calculation by multiplying hours 
per day and total years; they defined that higher values from 
this calculation provided for greater probability of altered 
PFT results. The main difference of their study from ours was 
that the number of days per week that people were exposed 
to biomass smoke was not added to their calculation.
study limitations
If it were possible to perform pulmonary imaging studies, 
particularly CT of the lungs, it would be possible to dif-
ferentiate chronic bronchitis from emphysema and show 
reticulonodular appearance and fibrosis that could be 
suggestive for restrictive lung disease.
Conclusion
Biomass exposure is a very important public health problem 
among females, especially in developing countries. The risk 
of developing problems in lung functions begins after expo-
sure to smoke for .15 years. Biomass smoke is responsible 
for both obstructive and restrictive pulmonary diseases. 
Precautions must be taken for populations living in these 
kinds of rural areas, and people must be educated about the 
adverse effects of biomass smoke.
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